Donisi Health is a medical technology company providing user-friendly in-home health detection solutions for patients with congestive heart failure (CHF) and other chronic diseases.
Donisi enables a user-friendly preemptive approach to cardiac and pulmonary health monitoring in the home, helping to optimize the continuum of care for patients with CHF and other chronic diseases and avoid unnecessary rehospitalization.
Based on Donisi's FDA-cleared technology and backed by 11 granted patents, Donisi's contact-free health detection works free from wires, wearables, and patches. The company's patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators.
Donisi's clinically validated contact-free technology can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Donisi Health Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 1, 2022
www.fdanews.com
Donisi Health Gets FDA's De Novo Clearance for Its Gili Biosensor System
#Customers
Apr 6, 2022
www.dicardiology.com
Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home
#Customers
Apr 4, 2022
www.prnewswire.com
Donisi Health Presents Data at ACC22 Demonstrating Accuracy of a Contact-Free Medical Device that Detects Pulmonary Congestion in CHF Patients at Home
#Customers
Apr 12, 2021
www.mobihealthnews.com
Israeli startup Donisi Health lands De Novo for AI-enabled contactless monitor
#Expand
Aug 27, 2020
www.calcalistech.com
250 companies and $6.5 billion: An in-depth look at Israel's healthtech industry